Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel With or Without Bevacizumab in Angiosarcoma
NCT01303497Phase 2Completed
- Sponsor
- Centre Oscar Lambret
- Start
- Sep 2010
- Primary completion
- Apr 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in angiosarcoma, sponsored by Centre Oscar Lambret. Started Sep 2010; status: completed.
02
Drugs
bevacizumab
03
Conditions
angiosarcoma
Beyond the preview
Go deeper on NCT01303497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01303497.